40
Participants
Start Date
July 7, 2018
Primary Completion Date
March 31, 2022
Study Completion Date
September 15, 2022
Atezolizumab
"* Induction (four or six 21-day cycles) : Atezolizumab 1200 mg / iv + carboplatin 5 AUCs + pemetrexed 500 mg/m2~* Maintenance (21-day cycles): atezolizumab 1200 mg/iv + pemetrexed 500 mg/m2."
Complejo Hospitalario de la Coruña, A Coruña
Hospital Dr. Josep Trueta, Girona
Hospital Fundación Jiménez Díaz, Madrid
Complexo Hospitalario Universitario de Vigo, Vigo
Hospital General Universitario de Valencia, Valencia
Hospital La Fe, Valencia
Hospital Clínico Universitario de Valladolid, Valladolid
Hospital General Universitario de Elche, Elche
Hospital Universitari Germans Tries i Pujol, Badalona
Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat
Hospital Insular de Gran Canaria, Las Palmas de Gran Canaria
H. La Paz, Madrid
Hospital General de Alicante, Alicante
H.U.Vall D´Hebrón, Barcelona
Hospital de Santa Creu i Sant Pau, Barcelona
Spanish Lung Cancer Group
OTHER